Already a print subscriber?
Already a digital subscriber?
Never Miss a Story
Activate Print Subscription
Manage My Account
Celebs & Gossip
Things to Do
Home & Design
Sex & Dating
Find a Home
Print Offers Online
Daily News logo
PhillyPharma Archive: January, 2013
Follow Philly.com PhillyPharma :
Health & Pharma
With lower litigation costs, J&J says fourth quarter net earnings rose more than 1000 percent
Tue, Jan 22, 2013, 8:46 AM
Helped by dramatically lower litigation costs, health-care giant Johnson & Johnson said Tuesday that its net earnings rose to $2.57 billion...
Doctor on shifting causes of death: 'Automobile era' to the 'pharmaceutical era'
Mon, Jan 21, 2013, 12:59 PM
Dr. Jeanmarie Perrone, whose specialties are emergency medicine and toxicology, said in an interview last week that we have changed eras when...
Kittens in SEC filings? Pfizer pegs Zoetis IPO at $22 to $25 per share
Fri, Jan 18, 2013, 2:10 PM
Drugmaker Pfizer filed a notice with the Securities and Exchange Commission estimating that its spinoff of its animal drug business called...
FTC report says pharma companies engaged in record 40 pay-to-delay deals
Fri, Jan 18, 2013, 8:28 AM
The Federal Trade Commission is not at all pleased with pharmaceutical companies, branded and generic alike. The FTC's basic mission is to...
Finding better ways to treat disease in developing countries
Thu, Jan 17, 2013, 6:06 AM
Allan Pamba is the director of engagement and access initiatives in GlaxoSmithKline's Developing Countries Market Access Unit. Before he went...
Teva hires Olympian Apolo Anton Ohno to talk about exercise-induced bronchospasm
Thu, Jan 17, 2013, 3:31 PM
One of the cultural trend-setters in the soul patch category, Olympic short-track speed skater Apolo Anton Ohno will try to help Teva Pharmaceuticals...
Neglected diseases get some attention
Wed, Jan 16, 2013, 9:31 AM
In marking the first anniversary of their gathering, the groups and drug companies involved in the London Declaration on Neglected Tropical...
AstraZeneca shakes up leadership under new CEO Pascal Soriot
Tue, Jan 15, 2013, 1:58 PM
Pascal Soriot, the still-new chief executive officer of AstraZeneca, said Tuesday that he was changing the leadership lineup below his spot...
David Sell is a sports web producer. In previous lives, he has been a reporter and editor in the Sports, Metro and Business sections.